These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3862698)

  • 1. Pilocarpine used to stimulate normal saliva production.
    J Am Dent Assoc; 1985 Aug; 111(2):310. PubMed ID: 3862698
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia.
    Wiseman LR; Faulds D
    Drugs; 1995 Jan; 49(1):143-55. PubMed ID: 7705213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
    Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N
    Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral pilocarpine (Salagen)--a recently approved salivary stimulant.
    Wynn RL
    Gen Dent; 1996; 44(1):26, 29-30. PubMed ID: 8940567
    [No Abstract]   [Full Text] [Related]  

  • 5. Transdermal pilocarpine on the skin over salivary glands to increase salivation: an in vivo study.
    Ishida N; Katsura A; Takagaki K; Arakawa H; Shimada T; Mizuno S; Sai Y; Kato Y; Nakamura H; Suga Y; Matsushita R
    BMC Oral Health; 2024 Aug; 24(1):881. PubMed ID: 39095752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilocarpine alters caries development in partially-desalivated rats.
    O'Connell AC; Pearson SK; Bowen WH
    J Dent Res; 1994 Mar; 73(3):637-43. PubMed ID: 8163734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction.
    Fox PC; van der Ven PF; Baum BJ; Mandel ID
    Oral Surg Oral Med Oral Pathol; 1986 Mar; 61(3):243-8. PubMed ID: 3517744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of pilocarpine in postradiation xerostomia.
    Greenspan D; Daniels TE
    Cancer; 1987 Mar; 59(6):1123-5. PubMed ID: 3815287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 0.1% pilocarpine mouthwash on xerostomia: double-blind, randomised controlled trial.
    Kim JH; Ahn HJ; Choi JH; Jung DW; Kwon JS
    J Oral Rehabil; 2014 Mar; 41(3):226-35. PubMed ID: 24527846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
    Johnson JT; Ferretti GA; Nethery WJ; Valdez IH; Fox PC; Ng D; Muscoplat CC; Gallagher SC
    N Engl J Med; 1993 Aug; 329(6):390-5. PubMed ID: 8326972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilocarpine disposition and salivary flow responses following intravenous administration to dogs.
    Weaver ML; Tanzer JM; Kramer PA
    Pharm Res; 1992 Aug; 9(8):1064-9. PubMed ID: 1409379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilocarpine used to treat xerostomia in patients submitted to radioactive iodine therapy: a pilot study.
    Almeida JP; Kowalski LP
    Braz J Otorhinolaryngol; 2010; 76(5):659-62. PubMed ID: 20963353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study.
    Nagler RM; Nagler A
    Bone Marrow Transplant; 1999 May; 23(10):1007-11. PubMed ID: 10373066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
    Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
    Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of cevimeline vs. pilocarpine in the secretion of saliva: a pilot study.
    Brimhall J; Jhaveri MA; Yepes JF
    Spec Care Dentist; 2013; 33(3):123-7. PubMed ID: 23600983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of long-term pilocarpine due to increased muscarinic acetylcholine receptor 3 in salivary glands.
    Minagi HO; Ikai K; Araie T; Sakai M; Sakai T
    Biochem Biophys Res Commun; 2018 Sep; 503(2):1098-1102. PubMed ID: 29953856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilocarpine in the prevention of postirradiation xerostomia.
    Lajtman Z; Krajina Z; Krpan D; Vincelj J; Borcić V; Popović-Kovacić J
    Acta Med Croatica; 2000; 54(2):65-7. PubMed ID: 11028111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia).
    Fox PC; Atkinson JC; Macynski AA; Wolff A; Kung DS; Valdez IH; Jackson W; Delapenha RA; Shiroky J; Baum BJ
    Arch Intern Med; 1991 Jun; 151(6):1149-52. PubMed ID: 2043017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).
    Malallah OS; Garcia CMA; Proctor GB; Forbes B; Royall PG
    Int J Pharm; 2018 Apr; 541(1-2):157-166. PubMed ID: 29425763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tramadol-induced oral dryness and pilocarpine treatment: effects on total protein and IgA.
    Looström H; Akerman S; Ericson D; Tobin G; Götrick B
    Arch Oral Biol; 2011 Apr; 56(4):395-400. PubMed ID: 21112044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.